tiprankstipranks
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market
Holding EWTX?
Track your performance easily

Edgewise Therapeutics (EWTX) Financial Statements

281 Followers

Edgewise Therapeutics Financial Overview

Edgewise Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.491; its P/E ratio is -21.42; Edgewise Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -34.13M$ -31.50M$ -34.75M$ -33.86M$ -29.45M
EBITDA$ -33.57M$ -27.79M$ -34.23M$ -33.33M$ -28.95M
Net Income Common Stockholders$ -34.13M$ -31.50M$ -28.52M$ -30.14M$ -25.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 492.54M$ 511.75M$ 532.76M$ 318.39M$ 289.70M
Total Assets$ 511.28M$ 531.65M$ 553.81M$ 340.04M$ 311.36M
Total Debt$ 4.44M$ 4.99M$ 5.25M$ 5.41M$ 5.53M
Net Debt$ -488.10M$ -506.77M$ -527.51M$ -312.98M$ -284.17M
Total Liabilities$ 22.41M$ 21.17M$ 18.86M$ 21.20M$ 20.94M
Stockholders Equity$ 488.88M$ 510.46M$ 534.93M$ 318.83M$ 290.43M
Cash Flow-
Free Cash Flow$ -27.37M$ -26.32M$ -28.89M$ -26.99M$ -22.52M
Operating Cash Flow$ -27.37M$ -26.10M$ -28.60M$ -26.83M$ -22.06M
Investing Cash Flow$ 25.36M$ 37.37M$ -268.31M$ 26.98M$ 23.42M
Financing Cash Flow$ 3.33M$ 1.95M$ 241.07M$ 52.99M$ -211.00K
Currency in USD

Edgewise Therapeutics Earnings and Revenue History

Edgewise Therapeutics Debt to Assets

Edgewise Therapeutics Cash Flow

Edgewise Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis